Global Gene Therapy Medicine Market Growth (Status and Outlook) 2023-2029

March 2023 | 89 pages | ID: G1B0B7748FE1EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Gene Therapy Medicine Industry Forecast” looks at past sales and reviews total world Gene Therapy Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Therapy Medicine sales for 2023 through 2029. With Gene Therapy Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy Medicine industry.

This Insight Report provides a comprehensive analysis of the global Gene Therapy Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Therapy Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Therapy Medicine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy Medicine.

The global Gene Therapy Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Gene Therapy Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Gene Therapy Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Gene Therapy Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Gene Therapy Medicine players cover Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical Inc. and Advantagene, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy Medicine market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
  • Oral
  • Injection
Segmentation by application
  • Cancer
  • Monogenic
  • Infectious Disease
  • Cardiovascular Disease
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Bluebird Bio
  • Sangamo
  • Spark Therapeutics
  • Dimension Therapeutics
  • Avalanche Bio
  • Celladon
  • Vical Inc.
  • Advantagene
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Gene Therapy Medicine Market Size 2018-2029
  2.1.2 Gene Therapy Medicine Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Gene Therapy Medicine Segment by Type
  2.2.1 Oral
  2.2.2 Injection
2.3 Gene Therapy Medicine Market Size by Type
  2.3.1 Gene Therapy Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Gene Therapy Medicine Market Size Market Share by Type (2018-2023)
2.4 Gene Therapy Medicine Segment by Application
  2.4.1 Cancer
  2.4.2 Monogenic
  2.4.3 Infectious Disease
  2.4.4 Cardiovascular Disease
  2.4.5 Other
2.5 Gene Therapy Medicine Market Size by Application
  2.5.1 Gene Therapy Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Gene Therapy Medicine Market Size Market Share by Application (2018-2023)

3 GENE THERAPY MEDICINE MARKET SIZE BY PLAYER

3.1 Gene Therapy Medicine Market Size Market Share by Players
  3.1.1 Global Gene Therapy Medicine Revenue by Players (2018-2023)
  3.1.2 Global Gene Therapy Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Gene Therapy Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 GENE THERAPY MEDICINE BY REGIONS

4.1 Gene Therapy Medicine Market Size by Regions (2018-2023)
4.2 Americas Gene Therapy Medicine Market Size Growth (2018-2023)
4.3 APAC Gene Therapy Medicine Market Size Growth (2018-2023)
4.4 Europe Gene Therapy Medicine Market Size Growth (2018-2023)
4.5 Middle East & Africa Gene Therapy Medicine Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Gene Therapy Medicine Market Size by Country (2018-2023)
5.2 Americas Gene Therapy Medicine Market Size by Type (2018-2023)
5.3 Americas Gene Therapy Medicine Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Gene Therapy Medicine Market Size by Region (2018-2023)
6.2 APAC Gene Therapy Medicine Market Size by Type (2018-2023)
6.3 APAC Gene Therapy Medicine Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Gene Therapy Medicine by Country (2018-2023)
7.2 Europe Gene Therapy Medicine Market Size by Type (2018-2023)
7.3 Europe Gene Therapy Medicine Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Gene Therapy Medicine by Region (2018-2023)
8.2 Middle East & Africa Gene Therapy Medicine Market Size by Type (2018-2023)
8.3 Middle East & Africa Gene Therapy Medicine Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL GENE THERAPY MEDICINE MARKET FORECAST

10.1 Global Gene Therapy Medicine Forecast by Regions (2024-2029)
  10.1.1 Global Gene Therapy Medicine Forecast by Regions (2024-2029)
  10.1.2 Americas Gene Therapy Medicine Forecast
  10.1.3 APAC Gene Therapy Medicine Forecast
  10.1.4 Europe Gene Therapy Medicine Forecast
  10.1.5 Middle East & Africa Gene Therapy Medicine Forecast
10.2 Americas Gene Therapy Medicine Forecast by Country (2024-2029)
  10.2.1 United States Gene Therapy Medicine Market Forecast
  10.2.2 Canada Gene Therapy Medicine Market Forecast
  10.2.3 Mexico Gene Therapy Medicine Market Forecast
  10.2.4 Brazil Gene Therapy Medicine Market Forecast
10.3 APAC Gene Therapy Medicine Forecast by Region (2024-2029)
  10.3.1 China Gene Therapy Medicine Market Forecast
  10.3.2 Japan Gene Therapy Medicine Market Forecast
  10.3.3 Korea Gene Therapy Medicine Market Forecast
  10.3.4 Southeast Asia Gene Therapy Medicine Market Forecast
  10.3.5 India Gene Therapy Medicine Market Forecast
  10.3.6 Australia Gene Therapy Medicine Market Forecast
10.4 Europe Gene Therapy Medicine Forecast by Country (2024-2029)
  10.4.1 Germany Gene Therapy Medicine Market Forecast
  10.4.2 France Gene Therapy Medicine Market Forecast
  10.4.3 UK Gene Therapy Medicine Market Forecast
  10.4.4 Italy Gene Therapy Medicine Market Forecast
  10.4.5 Russia Gene Therapy Medicine Market Forecast
10.5 Middle East & Africa Gene Therapy Medicine Forecast by Region (2024-2029)
  10.5.1 Egypt Gene Therapy Medicine Market Forecast
  10.5.2 South Africa Gene Therapy Medicine Market Forecast
  10.5.3 Israel Gene Therapy Medicine Market Forecast
  10.5.4 Turkey Gene Therapy Medicine Market Forecast
  10.5.5 GCC Countries Gene Therapy Medicine Market Forecast
10.6 Global Gene Therapy Medicine Forecast by Type (2024-2029)
10.7 Global Gene Therapy Medicine Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Bluebird Bio
  11.1.1 Bluebird Bio Company Information
  11.1.2 Bluebird Bio Gene Therapy Medicine Product Offered
  11.1.3 Bluebird Bio Gene Therapy Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Bluebird Bio Main Business Overview
  11.1.5 Bluebird Bio Latest Developments
11.2 Sangamo
  11.2.1 Sangamo Company Information
  11.2.2 Sangamo Gene Therapy Medicine Product Offered
  11.2.3 Sangamo Gene Therapy Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Sangamo Main Business Overview
  11.2.5 Sangamo Latest Developments
11.3 Spark Therapeutics
  11.3.1 Spark Therapeutics Company Information
  11.3.2 Spark Therapeutics Gene Therapy Medicine Product Offered
  11.3.3 Spark Therapeutics Gene Therapy Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Spark Therapeutics Main Business Overview
  11.3.5 Spark Therapeutics Latest Developments
11.4 Dimension Therapeutics
  11.4.1 Dimension Therapeutics Company Information
  11.4.2 Dimension Therapeutics Gene Therapy Medicine Product Offered
  11.4.3 Dimension Therapeutics Gene Therapy Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Dimension Therapeutics Main Business Overview
  11.4.5 Dimension Therapeutics Latest Developments
11.5 Avalanche Bio
  11.5.1 Avalanche Bio Company Information
  11.5.2 Avalanche Bio Gene Therapy Medicine Product Offered
  11.5.3 Avalanche Bio Gene Therapy Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Avalanche Bio Main Business Overview
  11.5.5 Avalanche Bio Latest Developments
11.6 Celladon
  11.6.1 Celladon Company Information
  11.6.2 Celladon Gene Therapy Medicine Product Offered
  11.6.3 Celladon Gene Therapy Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Celladon Main Business Overview
  11.6.5 Celladon Latest Developments
11.7 Vical Inc.
  11.7.1 Vical Inc. Company Information
  11.7.2 Vical Inc. Gene Therapy Medicine Product Offered
  11.7.3 Vical Inc. Gene Therapy Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Vical Inc. Main Business Overview
  11.7.5 Vical Inc. Latest Developments
11.8 Advantagene
  11.8.1 Advantagene Company Information
  11.8.2 Advantagene Gene Therapy Medicine Product Offered
  11.8.3 Advantagene Gene Therapy Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Advantagene Main Business Overview
  11.8.5 Advantagene Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Gene Therapy Medicine Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Injection
Table 4. Gene Therapy Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Gene Therapy Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Gene Therapy Medicine Market Size Market Share by Type (2018-2023)
Table 7. Gene Therapy Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Gene Therapy Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Gene Therapy Medicine Market Size Market Share by Application (2018-2023)
Table 10. Global Gene Therapy Medicine Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Gene Therapy Medicine Revenue Market Share by Player (2018-2023)
Table 12. Gene Therapy Medicine Key Players Head office and Products Offered
Table 13. Gene Therapy Medicine Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gene Therapy Medicine Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Gene Therapy Medicine Market Size Market Share by Regions (2018-2023)
Table 18. Global Gene Therapy Medicine Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Gene Therapy Medicine Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Gene Therapy Medicine Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Gene Therapy Medicine Market Size Market Share by Country (2018-2023)
Table 22. Americas Gene Therapy Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Gene Therapy Medicine Market Size Market Share by Type (2018-2023)
Table 24. Americas Gene Therapy Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Gene Therapy Medicine Market Size Market Share by Application (2018-2023)
Table 26. APAC Gene Therapy Medicine Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Gene Therapy Medicine Market Size Market Share by Region (2018-2023)
Table 28. APAC Gene Therapy Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Gene Therapy Medicine Market Size Market Share by Type (2018-2023)
Table 30. APAC Gene Therapy Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Gene Therapy Medicine Market Size Market Share by Application (2018-2023)
Table 32. Europe Gene Therapy Medicine Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Gene Therapy Medicine Market Size Market Share by Country (2018-2023)
Table 34. Europe Gene Therapy Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Gene Therapy Medicine Market Size Market Share by Type (2018-2023)
Table 36. Europe Gene Therapy Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Gene Therapy Medicine Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Gene Therapy Medicine Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Gene Therapy Medicine Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Gene Therapy Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Gene Therapy Medicine Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Gene Therapy Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Gene Therapy Medicine Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Gene Therapy Medicine
Table 45. Key Market Challenges & Risks of Gene Therapy Medicine
Table 46. Key Industry Trends of Gene Therapy Medicine
Table 47. Global Gene Therapy Medicine Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Gene Therapy Medicine Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Gene Therapy Medicine Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Gene Therapy Medicine Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Bluebird Bio Details, Company Type, Gene Therapy Medicine Area Served and Its Competitors
Table 52. Bluebird Bio Gene Therapy Medicine Product Offered
Table 53. Bluebird Bio Gene Therapy Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Bluebird Bio Main Business
Table 55. Bluebird Bio Latest Developments
Table 56. Sangamo Details, Company Type, Gene Therapy Medicine Area Served and Its Competitors
Table 57. Sangamo Gene Therapy Medicine Product Offered
Table 58. Sangamo Main Business
Table 59. Sangamo Gene Therapy Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Sangamo Latest Developments
Table 61. Spark Therapeutics Details, Company Type, Gene Therapy Medicine Area Served and Its Competitors
Table 62. Spark Therapeutics Gene Therapy Medicine Product Offered
Table 63. Spark Therapeutics Main Business
Table 64. Spark Therapeutics Gene Therapy Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Spark Therapeutics Latest Developments
Table 66. Dimension Therapeutics Details, Company Type, Gene Therapy Medicine Area Served and Its Competitors
Table 67. Dimension Therapeutics Gene Therapy Medicine Product Offered
Table 68. Dimension Therapeutics Main Business
Table 69. Dimension Therapeutics Gene Therapy Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Dimension Therapeutics Latest Developments
Table 71. Avalanche Bio Details, Company Type, Gene Therapy Medicine Area Served and Its Competitors
Table 72. Avalanche Bio Gene Therapy Medicine Product Offered
Table 73. Avalanche Bio Main Business
Table 74. Avalanche Bio Gene Therapy Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Avalanche Bio Latest Developments
Table 76. Celladon Details, Company Type, Gene Therapy Medicine Area Served and Its Competitors
Table 77. Celladon Gene Therapy Medicine Product Offered
Table 78. Celladon Main Business
Table 79. Celladon Gene Therapy Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Celladon Latest Developments
Table 81. Vical Inc. Details, Company Type, Gene Therapy Medicine Area Served and Its Competitors
Table 82. Vical Inc. Gene Therapy Medicine Product Offered
Table 83. Vical Inc. Main Business
Table 84. Vical Inc. Gene Therapy Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Vical Inc. Latest Developments
Table 86. Advantagene Details, Company Type, Gene Therapy Medicine Area Served and Its Competitors
Table 87. Advantagene Gene Therapy Medicine Product Offered
Table 88. Advantagene Main Business
Table 89. Advantagene Gene Therapy Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Advantagene Latest Developments

LIST OF FIGURES

Figure 1. Gene Therapy Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy Medicine Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Gene Therapy Medicine Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Gene Therapy Medicine Sales Market Share by Country/Region (2022)
Figure 8. Gene Therapy Medicine Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Gene Therapy Medicine Market Size Market Share by Type in 2022
Figure 10. Gene Therapy Medicine in Cancer
Figure 11. Global Gene Therapy Medicine Market: Cancer (2018-2023) & ($ Millions)
Figure 12. Gene Therapy Medicine in Monogenic
Figure 13. Global Gene Therapy Medicine Market: Monogenic (2018-2023) & ($ Millions)
Figure 14. Gene Therapy Medicine in Infectious Disease
Figure 15. Global Gene Therapy Medicine Market: Infectious Disease (2018-2023) & ($ Millions)
Figure 16. Gene Therapy Medicine in Cardiovascular Disease
Figure 17. Global Gene Therapy Medicine Market: Cardiovascular Disease (2018-2023) & ($ Millions)
Figure 18. Gene Therapy Medicine in Other
Figure 19. Global Gene Therapy Medicine Market: Other (2018-2023) & ($ Millions)
Figure 20. Global Gene Therapy Medicine Market Size Market Share by Application in 2022
Figure 21. Global Gene Therapy Medicine Revenue Market Share by Player in 2022
Figure 22. Global Gene Therapy Medicine Market Size Market Share by Regions (2018-2023)
Figure 23. Americas Gene Therapy Medicine Market Size 2018-2023 ($ Millions)
Figure 24. APAC Gene Therapy Medicine Market Size 2018-2023 ($ Millions)
Figure 25. Europe Gene Therapy Medicine Market Size 2018-2023 ($ Millions)
Figure 26. Middle East & Africa Gene Therapy Medicine Market Size 2018-2023 ($ Millions)
Figure 27. Americas Gene Therapy Medicine Value Market Share by Country in 2022
Figure 28. United States Gene Therapy Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 29. Canada Gene Therapy Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 30. Mexico Gene Therapy Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 31. Brazil Gene Therapy Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 32. APAC Gene Therapy Medicine Market Size Market Share by Region in 2022
Figure 33. APAC Gene Therapy Medicine Market Size Market Share by Type in 2022
Figure 34. APAC Gene Therapy Medicine Market Size Market Share by Application in 2022
Figure 35. China Gene Therapy Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 36. Japan Gene Therapy Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 37. Korea Gene Therapy Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 38. Southeast Asia Gene Therapy Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 39. India Gene Therapy Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 40. Australia Gene Therapy Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 41. Europe Gene Therapy Medicine Market Size Market Share by Country in 2022
Figure 42. Europe Gene Therapy Medicine Market Size Market Share by Type (2018-2023)
Figure 43. Europe Gene Therapy Medicine Market Size Market Share by Application (2018-2023)
Figure 44. Germany Gene Therapy Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 45. France Gene Therapy Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 46. UK Gene Therapy Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 47. Italy Gene Therapy Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 48. Russia Gene Therapy Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 49. Middle East & Africa Gene Therapy Medicine Market Size Market Share by Region (2018-2023)
Figure 50. Middle East & Africa Gene Therapy Medicine Market Size Market Share by Type (2018-2023)
Figure 51. Middle East & Africa Gene Therapy Medicine Market Size Market Share by Application (2018-2023)
Figure 52. Egypt Gene Therapy Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 53. South Africa Gene Therapy Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 54. Israel Gene Therapy Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 55. Turkey Gene Therapy Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 56. GCC Country Gene Therapy Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 57. Americas Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 58. APAC Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 59. Europe Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 60. Middle East & Africa Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 61. United States Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 62. Canada Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 63. Mexico Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 64. Brazil Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 65. China Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 66. Japan Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 67. Korea Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 68. Southeast Asia Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 69. India Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 70. Australia Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 71. Germany Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 72. France Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 73. UK Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 74. Italy Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 75. Russia Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 76. Spain Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 77. Egypt Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 78. South Africa Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 79. Israel Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 80. Turkey Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 81. GCC Countries Gene Therapy Medicine Market Size 2024-2029 ($ Millions)
Figure 82. Global Gene Therapy Medicine Market Size Market Share Forecast by Type (2024-2029)
Figure 83. Global Gene Therapy Medicine Market Size Market Share Forecast by Application (2024-2029)


More Publications